Specialist CRO for clinical trial administration and study support, announces a new board of directors to help continue the company's unprecedented growth
The new board will be led by Phlexglobal founder and chief executive officer Nicola Murgatroyd.
Joining Murgatroyd on the board is Karen Roy, who successfully launched PhlexEview last year, and has taken up the position of global business development director.
Also joining the board are Stella Donoghue, recently appointed as finance director, and Nigel Murgatroyd who takes up the position of commercial director.
Donoghue specialises in supporting entrepreneurial SME's in their high growth phase which, together with Nigel Murgatroyd's extensive commercial experience, will facilitate Phlexglobal's ventures into new markets and territories.
Ray Clarke, founder and managing director of Datacare Business Systems, and Stephen Swiatek, UK sales director with a pan-European German company both join as non-executive directors.
Chief executive officer, Nicola Murgatroyd, commented, "The time is right to share the running of the company and, together with Nigel, I am delighted to welcome Stella, Karen, Ray and Stephen to the board.
"With them, I am looking forward to continuing Phlexglobal's tradition of clinical study support leadership and innovation in the pharmaceutical sector and working to achieve our next stage of growth".
Phlexglobal counts 15 of the top 20 pharmaceutical companies across the globe as its clients.
Complementing these core clinical support services, the company provides an electronic centralised management of trial master file documentation.
